|
시장보고서
상품코드
2077598
페노바르비탈 시장 : 적응증별, 제형별, 유통 경로별, 지역별Phenobarbital Market, By Indication, By Dosage Form, By Distribution Channel, By Geography |
||||||
페노바르비탈 시장은 2026년에 18억 3,000만 달러 규모가 될 것으로 추정되며, 2033년까지 26억 1,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 5.2%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 18억 3,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간의 CAGR: | 5.20% | 2033년 시장 규모 예측: | 26억 1,000만 달러 |
페노바르비탈은 발작의 치료 및 예방에 사용되는 의약품입니다. 발작을 유발하는 뇌 내의 비정상적인 전기적 활동을 조절함으로써 작용합니다. 이는 항경련제 및 진정제라고 불리는 약물의 일종입니다. 또한, 불안이나 긴장을 느끼는 사람이 긴장을 풀거나 잠들 수 있도록 돕기 위해 사용되기도 합니다. 이 의약품은 의사의 처방전이 없으면 구입할 수 없습니다.
이 약을 장기간 사용하면 몇 가지 위험이 따릅니다. 여기에는 체내의 특정 영양소(칼슘, 비타민 B군, 엽산, 비타민 D 등)의 대사나 흡수와 관련된 문제가 포함됩니다. 또한, 정상적인 세포 기능에 중요한 전해질인 인산의 혈중 농도를 낮출 가능성도 있습니다. 또한, 이 약을 장기간 복용하면 갑상선 호르몬과 관련된 문제가 발생할 수도 있습니다.
시장 역학
페노바르비탈은 간질 및 발작성 질환 치료에 있어 그 효능으로 잘 알려져 있습니다. 특히 의료 자원이 제한된 지역에서는 몇 가지 유형의 발작에 대한 1차 치료제로 간주되고 있습니다. 발작을 효과적으로 억제하는 이 약물의 효능이 시장 내 수요와 사용을 촉진하고 있습니다.
페노바르비탈 시장은 안전성이 높고 부작용이 적은 대체 항경련제의 등장으로 인해 제약을 받고 있습니다. 다양한 작용 기전과 특정 적응증을 가진 신약의 개발로 인해, 간질 및 발작성 질환의 치료에는 더욱 다양한 선택지가 존재합니다. 특히, 부작용이나 약물 상호작용을 최소화해야 하는 상황에서는 의료진이 페노바르비탈보다 이러한 새로운 약물을 처방할 가능성이 있습니다.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트도 제공하고 있습니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 페노바르비탈 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 세계 페노바르비탈 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 페노바르비탈 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 페노바르비탈 시장 : 적응증별, 2021-2033년
제5장 세계의 페노바르비탈 시장 : 제형별, 2021-2033년
제6장 세계의 페노바르비탈 시장 : 유통 채널별, 2021-2033년
제7장 세계의 페노바르비탈 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSM 26.07.08Phenobarbital Market is estimated to be valued at USD 1.83 Bn in 2026 and is expected to reach USD 2.61 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1.83 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.20% | 2033 Value Projection: | USD 2.61 Bn |
Phenobarbital is a medicine which is used to treat or prevent seizures. It works by regulating the abnormal electrical activity in the brain that causes seizures. It is a class of medications called anticonvulsants and sedatives. It is also sometimes used for to help a person relax or sleep when he/she is anxious or nervous. This medication is available only with a doctor's prescription.
There is risk associated with the use of this medication if it is used for a long time. These include problems with how the body uses or absorbs certain nutrients (e.g., calcium, B vitamins, folic acid, and vitamin D). It can also lower the blood levels of phosphate, an electrolyte that is important for normal cell function. Long-term use of this medication can also cause problems with thyroid hormones.
Market Dynamics
Phenobarbital is well-known for its effectiveness in the management of epilepsy and seizure disorders. It is regarded as a first-line treatment for several types of seizures, especially in areas with limited resources. The drug's ability to effectively stop seizures fuels demand for and use of it on the market.
The market for phenobarbital is constrained by the availability of substitute anti-epileptic medications with enhanced safety profiles and fewer adverse effects. There are additional alternatives for treating epilepsy and seizure disorders which is due to the development of new drugs with various mechanisms of action and focused indications. Especially, in situations when limiting adverse effects or drug interactions is important, healthcare practitioners may choose to prescribe these newer medications over phenobarbital.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global phenobarbital market based on the following parameters - company highlights, product portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Sanofi, Pfizer Inc., Novartis AG, H. Lundbeck A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals, Cipla Ltd., and Par Pharmaceutical
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global phenobarbital market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global phenobarbital market
Global Phenobarbital Market Detailed Segmentation:
- By Indication (Revenue, USD Bn, 2021 - 2033)
- Epilepsy
- Neonatal Seizures
- By Dosage Form (Revenue, USD Bn, 2021 - 2033)
- Tablets
- Capsules
- Injectables
- By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top Companies in the Global Phenobarbital Market
- Sanofi
- Pfizer Inc.
- Novartis AG
- Lundbeck A/S
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals
- Cipla Ltd.
- Par Pharmaceutical
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Indication
- Market Snippet, By Dosage Form
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Increasing prevalence of epilepsy
- Restraints
- Availability of alternative anti-epileptic Drugs
- Adverse effects and safety concerns
- Opportunities
- Increasing prevalence of neonatal seizures
- Drivers
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Mergers, Acquisitions and Collaborations
4. Global Phenobarbital Market, By Indication, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Epilepsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Neonatal Seizures
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
5. Global Phenobarbital Market, By Dosage Form, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Injectables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
6. Global Phenobarbital Market, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
7. Global Phenobarbital Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022 -2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- India
- China
- Japan
- Australia
- ASEAN
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033 (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033 (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis AG.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lundbeck A/S
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Hikma Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cipla Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Par Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analysts' Views
- Sanofi
9. Section
- References
- Research Methodology
- About us
